Characterization of Parkinson's disease-related pathogenic TMEM230 mutants

Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant...

Full description

Saved in:
Bibliographic Details
Published inAnimal cells and systems Vol. 22; no. 2; pp. 140 - 147
Main Authors Nam, Daleum, Kim, Hyejung, Choi, Dong-Joo, Bae, Yun-Hee, Lee, Byoung Dae, Son, Ilhong, Seol, Wongi
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 04.03.2018
Taylor & Francis Ltd
Taylor & Francis Group
한국통합생물학회
Subjects
Abbreviations
Alzheimer's disease
Coding
Dopamine receptors
Fetal calf serum
Flow cytometry
Fluorescence
Gel electrophoresis
Genes
Iodides
Leucine
LRRK2
LRRK2 protein
Movement disorders
MPP
Mutants
Mutation
Neurodegenerative diseases
Neurotoxicity
Parkinson's disease
Pathogenesis
Pathogenesis-related proteins
Polyimide resins
Polymerase chain reaction
Propidium iodide
Proteins
Reverse transcription
Sodium dodecyl sulfate
Sodium lauryl sulfate
Stability
TMEM230
vesicle trafficking
생물학
neurotoxicity
LRRK2
Parkinson’s disease
TMEM230
vesicle trafficking
Online AccessGet full text
ISSN1976-8354
2151-2485
DOI10.1080/19768354.2018.1453545

Cover

Abstract Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP + treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.
AbstractList Parkinson’s disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5–10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP + treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2 , function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.
Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP+ treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability.Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.
Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP + treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.
Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP+ treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP+ treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. Abbreviations: LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.
Parkinson’s disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5–10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in TMEM230 were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP+ treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, TMEM230 and LRRK2, function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. KCI Citation Count: 0
Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several pathogenic mutations in related genes have been identified. Mutations in were recently identified as a cause of autosomal dominant PD. However, the basic properties of the mutant proteins are not yet known. We examined stability and neurotoxicity, important characteristics of PD pathogenesis-related proteins, of WT TMEM230 and two pathogenic mutants, R78L and PG5ext, in a dopaminergic neuronal cell line. Our study showed that amount of protein expressed in the same vector backbone was R78L > WT > PG5ext. The stabilities of the mutant proteins were similar to each other, but lower than that of the WT. In addition, overexpression of mutants and WT TMEM230 caused similar levels of neurotoxicity upon MPP treatment when compared to the cells transfected with an empty vector. Because the proteins encoded by two PD-causing genes, and , function in vesicle trafficking, we tested whether they interact. LRRK2 neither interacts with, nor phosphorylates TMEM230. We also investigated the levels of several Rab proteins (Rab1A, 5, 7, 8A and 11) involved in vesicle trafficking after TMEM230 overexpression. However, there was no clear difference of any Rab proteins among cells transfected with an empty vector, TMEM230 WT and mutants-expressing cells, suggesting that TMEM230 does not directly regulate these Rab proteins. Thus, these TMEM230 PG5ext and R78L mutant proteins are not distinctly different from the WT proteins except for their stability. LRRK2: Leucine-rich repeat kinase 2; PD: Parkinson's disease; AD: Alzheimer's disease; RT-PCR: reverse transcription-polymerase chain reaction; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; FACS: fluorescence-activated cell sorting; PBS: phosphate buffered saline; FBS: fetal bovine serum; PI: propidium iodide.
Author Seol, Wongi
Choi, Dong-Joo
Kim, Hyejung
Bae, Yun-Hee
Lee, Byoung Dae
Son, Ilhong
Nam, Daleum
Author_xml – sequence: 1
  givenname: Daleum
  surname: Nam
  fullname: Nam, Daleum
  organization: InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University
– sequence: 2
  givenname: Hyejung
  surname: Kim
  fullname: Kim, Hyejung
  organization: InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University
– sequence: 3
  givenname: Dong-Joo
  surname: Choi
  fullname: Choi, Dong-Joo
  organization: Department of Pharmacology, School of Medicine, Ajou University
– sequence: 4
  givenname: Yun-Hee
  surname: Bae
  fullname: Bae, Yun-Hee
  organization: Department of Neuroscience, Graduate School, Kyung Hee University
– sequence: 5
  givenname: Byoung Dae
  surname: Lee
  fullname: Lee, Byoung Dae
  organization: Department of Physiology, School of Medicine, Kyung Hee University
– sequence: 6
  givenname: Ilhong
  surname: Son
  fullname: Son, Ilhong
  email: sonih@wku.ac.kr
  organization: Department of Neurology, Sanbon Medical Center, College of Medicine, Wonkwang University
– sequence: 7
  givenname: Wongi
  surname: Seol
  fullname: Seol, Wongi
  email: wseolha@gmail.com
  organization: InAm Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30460091$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002338212$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFkktvEzEUhUeoiKaFnwAaiQVlMcHvcVQJUUUFglqBUFhbHj8SJxM72E5R-fU4j1a0C1hdy_7O0b2-56Q68sGbqnoJwRACDt7BUcs4pmSIAORDSGg50yfVAEEKG0Q4PaoGW6bZQsfVSUoLABgCfPSsOsaAMABGcFB9Gc9llCqb6H7L7IKvg62_ybh0PgX_JtXaJSOTaaLpZTa6Xss8DzPjnaqn15fXCIN6tcnS5_S8empln8yLQz2tfny8nI4_N1dfP03GF1eNoiOWmxZArJHqDIHQAqU1RpZZamlHgG2pbVulDZHKKgY7qxEvFTIMIMAMWqnwafV27-ujFUvlRJBuV2dBLKO4-D6dCIIwggQUdrJndZALsY5uJePtTrC7CHEmZMxO9UZow6lFUhcZI6RrOUVEMaZta2FLOlK83u-91ptuZbQyPkfZPzB9-OLdvPR0IxjEHANeDM4OBjH83JiUxcolZfpeehM2SSCIGS2bQ21BXz9CF2ETfflWgUBZIuajdku9-ruj-1bu1lsAugdUDClFY-8RCMQ2RuIuRmIbI3GIUdGdP9Ipl3fxKIO5_r_qD3u18zbElfwVYq9Flrd9iDZKr1wS-N8WfwAd5t6_
CitedBy_id crossref_primary_10_1007_s12264_022_00862_5
crossref_primary_10_1016_j_neuroscience_2020_11_004
crossref_primary_10_3389_fnagi_2020_00235
crossref_primary_10_1093_hmg_ddab128
Cites_doi 10.1523/JNEUROSCI.20-16-06048.2000
10.1016/j.neurobiolaging.2017.03.014
10.1146/annurev-genom-082410-101440
10.1016/j.neurobiolaging.2016.10.004
10.1523/JNEUROSCI.19-01-00010.1999
10.1073/pnas.0508052102
10.1007/s00702-015-1438-9
10.1128/MCB.00914-13
10.1016/j.parkreldis.2016.12.015
10.1038/ng.3589
10.1016/j.yexcr.2008.02.015
10.1007/s12035-017-0542-2
10.5483/BMBRep.2010.43.4.233
10.1007/s00109-012-0984-y
10.1002/ajmg.b.32576
10.1002/jcp.26032
10.1016/j.yexcr.2009.09.014
10.1002/mds.27061
10.1186/s13041-015-0145-7
10.3389/fnmol.2017.00201
10.1523/JNEUROSCI.3642-15.2016
10.1016/j.neuron.2009.11.006
10.1523/JNEUROSCI.4650-14.2015
10.1007/978-3-319-49969-7
ContentType Journal Article
Copyright 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2018
2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2018 The Author(s)
Copyright_xml – notice: 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2018
– notice: 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group
– notice: 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2018 The Author(s)
DBID 0YH
AAYXX
CITATION
NPM
7QO
7SN
7TK
7TM
8FD
C1K
FR3
P64
RC3
7X8
5PM
DOA
ACYCR
DOI 10.1080/19768354.2018.1453545
DatabaseName Taylor & Francis Free Journals (Free resource, activated by CARLI)
CrossRef
PubMed
Biotechnology Research Abstracts
Ecology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
Genetics Abstracts
Biotechnology Research Abstracts
Technology Research Database
Nucleic Acids Abstracts
Engineering Research Database
Ecology Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
Genetics Abstracts


MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 0YH
  name: Taylor & Francis Journals Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate ANIMAL CELLS AND SYSTEMS
EISSN 2151-2485
EndPage 147
ExternalDocumentID oai_kci_go_kr_ARTI_4232140
oai_doaj_org_article_de85f2ad140644b78524c66df7f174b4
PMC6138308
30460091
10_1080_19768354_2018_1453545
1453545
Genre Article
Journal Article
GrantInformation_xml – fundername: Basic Science Research Program
  grantid: 2015R1C1A2A01051755 to WS
– fundername: InAm Neuroscience Research Center
– fundername: ;
– fundername: ;
  grantid: 2015R1C1A2A01051755 to WS
GroupedDBID .7F
.QJ
.UV
0YH
23M
2DF
4.4
5GY
9ZL
AAENE
AAHBH
ABCCY
ABDBF
ABFIM
ABHAV
ABPEM
ABTAI
ACGFS
ACIWK
ACPRK
ACUHS
ADBBV
ADCVX
AENEX
AFRAH
AGMYJ
AIJEM
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AVBZW
BBNVY
BCNDV
BENPR
BHPHI
CCCUG
CE4
EBD
EBS
EJD
ESX
EYRJQ
E~A
E~B
GROUPED_DOAJ
GTTXZ
H13
HCIFZ
HF~
HYE
HZ~
H~P
IPNFZ
J.P
M4Z
M7P
NA5
O9-
OK1
PIMPY
RIG
RPM
S-T
TDBHL
TEI
TFL
TFT
TFW
TUS
UT5
UU3
~S~
AAYXX
CITATION
8FE
8FH
AEUYN
AFKRA
CCPQU
KVFHK
LK8
NPM
PHGZM
PHGZT
PQGLB
PROAC
7QO
7SN
7TK
7TM
8FD
C1K
FR3
P64
RC3
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c596t-7013d2cbe411f0cdd32f6f5f5b40f75f77cde4acfc61bfd28c61163010361fac3
IEDL.DBID 0YH
ISSN 1976-8354
IngestDate Sun Mar 09 07:54:24 EDT 2025
Wed Aug 27 01:27:34 EDT 2025
Thu Aug 21 14:06:44 EDT 2025
Fri Jul 11 01:11:04 EDT 2025
Mon Jun 30 08:34:27 EDT 2025
Mon Jul 21 06:05:52 EDT 2025
Thu Apr 24 22:58:07 EDT 2025
Tue Jul 01 02:39:44 EDT 2025
Wed Dec 25 09:08:32 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords neurotoxicity
LRRK2
Parkinson’s disease
TMEM230
vesicle trafficking
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c596t-7013d2cbe411f0cdd32f6f5f5b40f75f77cde4acfc61bfd28c61163010361fac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.tandfonline.com/doi/abs/10.1080/19768354.2018.1453545
PMID 30460091
PQID 2020838977
PQPubID 1346338
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_4232140
proquest_miscellaneous_2136548527
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6138308
proquest_journals_2020838977
crossref_primary_10_1080_19768354_2018_1453545
doaj_primary_oai_doaj_org_article_de85f2ad140644b78524c66df7f174b4
pubmed_primary_30460091
informaworld_taylorfrancis_310_1080_19768354_2018_1453545
crossref_citationtrail_10_1080_19768354_2018_1453545
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-03-04
PublicationDateYYYYMMDD 2018-03-04
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-04
  day: 04
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Daejeon
PublicationTitle Animal cells and systems
PublicationTitleAlternate Anim Cells Syst (Seoul)
PublicationYear 2018
Publisher Taylor & Francis
Taylor & Francis Ltd
Taylor & Francis Group
한국통합생물학회
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
– name: Taylor & Francis Group
– name: 한국통합생물학회
References CIT0010
CIT0012
CIT0014
CIT0013
CIT0016
CIT0015
CIT0018
CIT0017
CIT0019
CIT0021
CIT0020
CIT0001
CIT0023
CIT0022
Kim MJ (CIT0011) 2017; 26
CIT0003
CIT0025
CIT0002
CIT0024
CIT0005
CIT0004
CIT0007
CIT0006
CIT0009
CIT0008
References_xml – ident: CIT0016
  doi: 10.1523/JNEUROSCI.20-16-06048.2000
– ident: CIT0010
  doi: 10.1016/j.neurobiolaging.2017.03.014
– ident: CIT0015
  doi: 10.1146/annurev-genom-082410-101440
– ident: CIT0006
  doi: 10.1016/j.neurobiolaging.2016.10.004
– ident: CIT0022
  doi: 10.1523/JNEUROSCI.19-01-00010.1999
– ident: CIT0021
  doi: 10.1073/pnas.0508052102
– ident: CIT0025
  doi: 10.1007/s00702-015-1438-9
– ident: CIT0017
  doi: 10.1128/MCB.00914-13
– ident: CIT0001
  doi: 10.1016/j.parkreldis.2016.12.015
– ident: CIT0004
  doi: 10.1038/ng.3589
– ident: CIT0020
  doi: 10.1016/j.yexcr.2008.02.015
– ident: CIT0024
  doi: 10.1007/s12035-017-0542-2
– ident: CIT0019
  doi: 10.5483/BMBRep.2010.43.4.233
– ident: CIT0007
  doi: 10.1007/s00109-012-0984-y
– volume: 26
  start-page: 729
  year: 2017
  ident: CIT0011
  publication-title: Hum Mol Genet
– ident: CIT0005
  doi: 10.1002/ajmg.b.32576
– ident: CIT0003
  doi: 10.1002/jcp.26032
– ident: CIT0008
  doi: 10.1016/j.yexcr.2009.09.014
– ident: CIT0014
  doi: 10.1002/mds.27061
– ident: CIT0009
  doi: 10.1186/s13041-015-0145-7
– ident: CIT0012
  doi: 10.3389/fnmol.2017.00201
– ident: CIT0023
  doi: 10.1523/JNEUROSCI.3642-15.2016
– ident: CIT0013
  doi: 10.1016/j.neuron.2009.11.006
– ident: CIT0002
  doi: 10.1523/JNEUROSCI.4650-14.2015
– ident: CIT0018
  doi: 10.1007/978-3-319-49969-7
SSID ssj0062089
Score 2.088573
Snippet Parkinson's disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5-10% of them are hereditary and several...
Parkinson’s disease (PD) is the second most common neurodegenerative disease. Although most PD cases are sporadic, 5–10% of them are hereditary and several...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 140
SubjectTerms Abbreviations
Alzheimer's disease
Coding
Dopamine receptors
Fetal calf serum
Flow cytometry
Fluorescence
Gel electrophoresis
Genes
Iodides
Leucine
LRRK2
LRRK2 protein
Movement disorders
MPP
Mutants
Mutation
Neurodegenerative diseases
Neurotoxicity
Parkinson's disease
Pathogenesis
Pathogenesis-related proteins
Polyimide resins
Polymerase chain reaction
Propidium iodide
Proteins
Reverse transcription
Sodium dodecyl sulfate
Sodium lauryl sulfate
Stability
TMEM230
vesicle trafficking
생물학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuCMor0KKAuIYmjl85QtWqIJZTK_VmxS9YFRK0jwO3_o3-vf6SzthJtFsh7YVTIttJnMnY8zme-YaQD77yIphKFL60rGBShaJllhaCVYZTw5W3GCg8-y7OLtjXS365keoLfcISPXAS3JHzigfaOlgIgOk2UnHKrBAuyABg2kQm0LIpx8VUmoMFLWPyuwqMbYG_NsbYHVUeYRkWoVuXgomCwznfskqRvP8edSmYnm4R_gVD73tTbpin0yfk8YAr80_pfZ6SB77bJw9Tpsm_z8i344mYOcVd5n3IMeI5Bn_dXt8s82GrpojRLd7lmKu4B_Wa2_x8djKDRUT-e405h5fPycXpyfnxWTEkUigsb8SqkIDzHLXGs6oKpXWupkEEHrhhZZA8SGmdZ60NVlQmOKrgCDgNU0CIKrS2fkH2ur7zr0juqGwEjHkuDGeuto3kjVd1gHtRC3LPCBsFqe3AMo7JLn7paiAjHeWvUf56kH9GPk6X_Uk0G7su-IxfaWqMLNmxAHRHD7qjd-lORprNb6xX8SdJSBlNdL2jA-9BIfSVncdn4_FHr68WGtYhXzRuf8NTM3Iw6ose5oYl3AW0E3CilBl5N1XDqMatmrbz_RraoPchg_5Cm5dJvaZXjXvZAPMyIrcUb0sW2zXd_GdkDgfspupSvf4fwntDHqE8oj8eOyB7q8XaHwJAW5m3cSzeAfZsMSw
  priority: 102
  providerName: Directory of Open Access Journals
Title Characterization of Parkinson's disease-related pathogenic TMEM230 mutants
URI https://www.tandfonline.com/doi/abs/10.1080/19768354.2018.1453545
https://www.ncbi.nlm.nih.gov/pubmed/30460091
https://www.proquest.com/docview/2020838977
https://www.proquest.com/docview/2136548527
https://pubmed.ncbi.nlm.nih.gov/PMC6138308
https://doaj.org/article/de85f2ad140644b78524c66df7f174b4
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002338212
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Animal Cells and Systems, 2018, 22(2), , pp.140-147
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLagFRIXxE6gjAJC4hRIHG85dkpHQ6Xh1EpwsuKtjAoJmswc-Pe85yzqVKAeOGXzkry8Z3_Pfgsh73zhRTCFyHxuWcakClnNLM0EKwynhitv0VF49UUsL9jZVz5aE3aDWSXq0KEPFBHHahTu2nSjRdzHAqZQXK9AwywFos7hnN8lhxSAIlr15d-W42AsaB6z4GGVDOuMTjz_amZveopR_G_EMIU5qNmEv-HRm2aV1-apxUPyYACY6XHPEY_IHd88Jvf6lJO_n5CzkylCc--AmbYhRdfn6AX2vkuHHZssOrl4l2LK4ha4bG3T89XpCnSJ9OcOUw93T8nF4vT8ZJkN-RQyyyuxzSTAPUet8awoQm6dK2kQgQduWB4kD1Ja51ltgxWFCY4qOAJcw0wQogi1LZ-Rg6Zt_AuSOiorAaLPheHMlbaSvPKqDNAWtUD1hLCRjNoOwcYx58UPXQwxSUfqa6S-HqifkA9TtV99tI3bKszxH02FMVh2vNFuLvUge9p5xQOtHeiSgP6MVJwyK4QLMoA-ZlhCqut_WG_jWknoE5vo8pYXeAvsoK_sOvaNx8tWX200qCOfNe6CQ68JORq5RQ9DRAetAG8CXJQyIW-mxyDcuGNTN77dQRk0QmTwvlDmec9c06fGLW1AewmRe2y3R4v9J836ewwgDhBOlbl6-R_f_Yrcx8tojceOyMF2s_OvAZ5tzSwK4IwcHs8_zRezuMjxB8FCLu4
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCNEL4t1AgYCQOIUmjl85QtVqW7o9baVysuJXWRUStI8D_54Z56HdCtQDp0TxK5nM2DP2zDeEfPCFF8EUIvO5ZRmTKmQ1szQTrDCcGq68xUDh6bmYXLDTS365EQuDbpVoQ4cOKCLO1SjcuBk9uMQdFLCG4oYFemYpkHUO9_wuuccVWBPA0_m3yTAbC5rHNHjYJMM2QxTPv7rZWp8ijP8NEFNYhJpF-JtCetOvcmOhOn5EHvYaZvq5Y4nH5I5vnpD7Xc7J30_J6eEI0dxFYKZtSDH2OYaBfVym_ZFNFqNcvEsxZ3ELbDa36Wx6NAVjIv25xtzDy2fk4vhodjjJ-oQKmeWVWGUS9D1HrfGsKEJunStpEIEHblgeJA9SWudZbYMVhQmOKriCvoapIEQRals-JztN2_g9kjoqKwGyz4XhzJW2krzyqgzQF7VA9YSwgYza9mjjmPTihy56UNKB-hqpr3vqJ-TT2OxXB7dxW4Mv-I_GyoiWHR-0iyvdC592XvFAawfGJKh_RipOmRXCBRnAIDMsIdXmH9aruFkSuswmurzlBd4DO-hrO49j4_Wq1dcLDfbIicZjcBg1IfsDt-h-jlhCL8CboC9KmZB3YzFINx7Z1I1v11AHvRAZvC_UedEx1_ip8Uwb1L2EyC2226LFdkkz_x4RxEGHU2WuXv7Hd78lDyaz6Zk-Ozn_-orsYlF0zWP7ZGe1WPvXoKutzJsojH8AdHwv8g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9UwELagCMQFsRMoEBASp0AWbzlC6dNr4VUcWglO1vMy5amQVG858O-ZcRb1VaAeODmKlyTjGfubeBbG3oQiSLCFzELueMaVhmzOXZlJXlhRWqGDI0fh2ZGcnvDDb2KwJlz1ZpWkQ0MXKCKu1STc5x4Gi7j3BW6h9L-CDLM0irrAa3Gd3RC6jhgp_z4dFmNZ5jELHnXJqM_gxPOvYba2pxjF_1IMU9yDmiX8DY9eNqu8sE9N7rI7PcBMP3QccY9dC819drNLOfn7ATvcGyM0dw6YaQspuT5HL7C3q7Q_scmik0vwKaUsbpHLFi49nu3PUJdIf20o9fDqITuZ7B_vTbM-n0LmRC3XmUK450tnAy8KyJ33VQkSBAjLc1AClHI-8LkDJwsLvtRYIlyjTBCygLmrHrGdpm3CE5b6UtUSRV9IK7ivXK1EHXQFOFbpkOoJ4wMZjeuDjVPOi5-m6GOSDtQ3RH3TUz9h78Zu5120jas6fKQ5GhtTsOx4o12eml72jA9aQDn3qEsi-rNKi5I7KT0oQH3M8oTVF2fYrOO_EugSm5jqihd4jexgztwiPpvK09acLQ2qIweGTsHxqQnbHbjF9EvECkdB3kS4qFTCXo3VKNx0YjNvQrvBNmSEyPF9sc3jjrnGT41H2oj2Eqa22G6LFts1zeJHDCCOEE5XuX76H9_9kt36-mlivhwcfX7GblNNNMzju2xnvdyE54jU1vZFlMU_WrUvGw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+Parkinson%27s+disease-related+pathogenic+TMEM230+mutants&rft.jtitle=Animal+cells+and+systems&rft.au=Nam%2C+Daleum&rft.au=Kim%2C+Hyejung&rft.au=Choi%2C+Dong-Joo&rft.au=Bae%2C+Yun-Hee&rft.date=2018-03-04&rft.issn=1976-8354&rft.volume=22&rft.issue=2&rft.spage=140&rft_id=info:doi/10.1080%2F19768354.2018.1453545&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-8354&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-8354&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-8354&client=summon